PMID: 9169963Jun 1, 1997Paper

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness

Journal of Clinical Psychopharmacology
J Sporn, Gary Sachs

Abstract

Anticonvulsants are used extensively in the treatment of bipolar disorder. Treating depression in bipolar disorder can be difficult because of the limited antidepressant effects of the standard mood stabilizers and the tendency of antidepressants to induce mania or decrease cycle length. Lamotrigine is a new anticonvulsant with few side effects that may have mood-stabilizing and elevating effects. Its mechanism of action probably involves the inhibition of excessive release of excitatory amino acids such as glutamate. Antiglutamatergic agents may be antidepressant and mood stabilizing. A case series of 16 patients treated with lamotrigine (dose range 50 mg to 250 mg, mean dose of responders = 141 mg) is presented along with two case reports. All patients were considered treatment-resistant bipolar type I or II. Patients were rated on average 5 weeks after starting lamotrigine using a semistructured follow-up form that included symptom rating, Clinical Global Impressions (CGI), and Global Assessment of Functioning (GAF) scores. Eight of 16 patients were rated as "responders" (CGI < or = 2) and had a mean increase of 16 in their GAF scores. Lamotrigine seems to have antidepressant and mood-stabilizing effects, but this requires c...Continue Reading

References

Jan 1, 1991·Epilepsia·M J LeachM A Critchley
Oct 22, 1991·European Journal of Pharmacology·R TrullasP Skolnick
Jan 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·E K SilbermanJ P Boulenger
Jul 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P N Patsalos, J W Sander
Jan 1, 1994·Epilepsia·A Richens
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·F ZippP A Fischer
Mar 1, 1994·Nō to shinkei = Brain and nerve·Y Ohtsuka, S Ohtahara
Sep 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P N Patsalos, J S Duncan
Sep 15, 1993·European Journal of Pharmacology·G NowakP Skolnick
Jan 1, 1993·Epilepsia·D SmithM Dewey
Jan 1, 1995·The Journal of Neuropsychiatry and Clinical Neurosciences·D BlumerB Hermann

❮ Previous
Next ❯

Citations

Jun 22, 2005·Current Treatment Options in Neurology·Andres M Kanner, Antoaneta J Balabanov
Nov 7, 2000·Biological Psychiatry·W C Drevets
Jan 13, 1999·Pediatric Clinics of North America·R A Kowatch, J P Bucci
Jan 29, 2002·Lancet·Bruno Müller-OerlinghausenMichael Bauer
Dec 21, 2000·Journal of Affective Disorders·S A MontgomeryJ Zajecka
Jun 11, 1999·Journal of Affective Disorders·T SuppesR M Post
Dec 19, 1998·Journal of Affective Disorders·D Marcotte
Jan 17, 2002·Neurochemistry International·K Y Vinod, M N Subhash
Oct 19, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C L BowdenT Suppes
Oct 19, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Berk
May 18, 2005·Psychiatry and Clinical Neurosciences·Michael BerkLesley Berk
Dec 28, 1999·Epilepsia·M V Lambert, M M Robertson
Jun 9, 2005·Epilepsia·Benedikt Amann, Heinz Grunze
Jul 23, 1999·Annals of the New York Academy of Sciences·W C Drevets
Apr 23, 2005·Annals of General Psychiatry·Danilo Arnone
Sep 18, 2001·Drugs·M BerkM Vorster
Jul 5, 2002·CNS Drugs·Kathryn J Macdonald, L Trevor Young
Dec 7, 2002·CNS Drugs·Gin S MalhiShahzad Salim
Jul 7, 2011·The Primary Care Companion to CNS Disorders·Nanjayya Bhagyalakshmi SubodhPratima Murthy
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·C Tannock
Jul 5, 2003·Current Medical Research and Opinion·Ben Green
Jul 9, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Cornelius SchüleRainer Rupprecht
Dec 1, 2010·Asian Journal of Psychiatry·Hsien-Te HuangDong-Sheng Tzeng
Mar 5, 2016·Clinical Pharmacokinetics·Patrick R Finley
Apr 27, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gérard EmilienMichel Bourin
Jun 5, 2003·Bipolar Disorders·Mukund GnanadesikanAlan J Gelenberg
Nov 11, 2003·Perspectives in Psychiatric Care·Susan McCabe
Apr 27, 2010·CNS Neuroscience & Therapeutics·Joseph BiedermanJanet Wozniak
May 20, 1999·Biological Psychiatry·M A HertzbergJ R Davidson
Nov 7, 1999·The Psychiatric Clinics of North America·S C Sonne, K T Brady
Nov 7, 1999·The Psychiatric Clinics of North America·L SanchezR Weller
Oct 6, 2000·Biological Psychiatry·S L McElroy, P E Keck
Feb 5, 2002·Expert Opinion on Pharmacotherapy·C BarriosP J Goodnick
Jul 1, 2015·Indian Journal of Psychiatry·Serap OflazFatma Akyuz
Aug 31, 1999·The Annals of Pharmacotherapy·I D Maidment
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·A GonzalezI Everall
Jul 23, 2003·Journal of Psychopharmacology·Adrian J LloydAllan H Young
Jun 1, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stacy M Ku, Ming-Hu Han
Jul 24, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Marianna MazzaSalvatore Mazza
Jun 30, 2005·Journal of Psychiatric Practice·Joseph F Goldberg
Nov 3, 1998·Epilepsia·R G SchliengerN H Shear

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.